{"id":"W4206274135","doi":"10.1016/j.ctro.2021.12.008","title":"Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)","year":2022,"lang":"en","type":"article","venue":"Clinical and Translational Radiation Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Varian Medical Systems; AstraZeneca","keywords":"Medicine; SABR volatility model; Oncology; Randomized controlled trial; Internal medicine; Lung cancer; Radiation therapy; Systemic therapy; Clinical endpoint; Context (archaeology); Quality of life (healthcare); Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00153858,0.0002206598,0.0009336032,0.0002106142,0.0002561598,0.00001664783,0.0001156657,0.000156671,0.0003899156],"category_scores_gemma":[0.0001606682,0.0001917182,0.0004265427,0.0002428665,0.0002048261,0.00006812414,0.00001075987,0.000339208,3.982452e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002427055,"about_ca_system_score_gemma":0.001586336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005430555,"about_ca_topic_score_gemma":0.0000127759,"domain_scores_codex":[0.9970642,0.0007866707,0.00111876,0.0005169681,0.0002587381,0.0002546804],"domain_scores_gemma":[0.9961194,0.002841751,0.0004870967,0.0001961667,0.0001100511,0.0002455039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9357104,0.002472324,0.003832039,0.00008595881,0.0004650755,0.00002265507,0.001165016,0.0005607771,0.000479231,0.00003876325,0.0004325451,0.05473524],"study_design_scores_gemma":[0.9416645,0.008063883,0.006399279,0.00008294997,0.0002631063,0.000006036484,0.00006825571,0.02289468,0.00003445467,0.0000799457,0.02021057,0.0002323949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9624374,0.01495333,0.002562263,0.009928766,0.000957389,0.008624897,0.0004272921,0.00003102294,0.00007763306],"genre_scores_gemma":[0.9880412,0.001673543,0.000634655,0.003649802,0.0005295571,0.004955281,0.0003052645,0.00003195328,0.0001787745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05450284,"threshold_uncertainty_score":0.7818041,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03669078119217174,"score_gpt":0.4070221651495956,"score_spread":0.3703313839574239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}